uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.


Posted March 08, 2007

FTC Files Against Maker of Calcium and Fertility Supplements

On January 29, 2007, the Federal Trade Commission (FTC) announced that it had filed civil contempt charges against Lane Labs, Inc., its president Andrew Lane, and William Lane for violating FTC orders entered in 2000 requiring them to have competent and reliable scientific evidence to substantiate ad claims and prohibiting deceptive claims about tests, studies, or research. The FTC alleged that Lane Labs and Andrew Lane violated the order against them by claiming that Fertil Male, a dietary supplement, enhances male fertility. The FTC also alleged that Lane Labs, Andrew Lane, and William Lane violated the FTC orders by claiming that AdvaCAL, a calcium supplement also sold as AAACa, is superior to other calcium products and on par with or superior to prescription drugs used to fight osteoporosis.

Join today to unlock all member benefits including full access to all recalls & warnings

Join Now

Join now at